Analysts expect Actinium Pharmaceuticals, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 35.00 M.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 90,000.00 | 0.00 | 0.00 | 35.00 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 70,690.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -9.92 M | -6.72 M | 2.66 M | 10.23 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 60,583.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -11.92 M | -7.74 M | 2.30 M | 9.24 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 65,636.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10.92 M | -7.23 M | 2.48 M | 9.73 M |
Analysts expect Actinium Pharmaceuticals, Inc. to report earnings per share of -0.23 for Q3 26, against a range of -0.24 to -0.22. The most recent reported quarter, Q2 26, came in at 0.89, a 568.4% beat against the -0.19 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.37 | -0.21 | -0.51 | -0.22 | -0.16 | -0.19 | -0.18 | 0.89 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.36 | -0.33 | -0.43 | -0.34 | -0.18 | -0.18 | -0.23 | -0.17 | -0.22 | -0.23 | -0.09 | -0.07 | -0.38 | -0.36 | -0.09 | 0.19 | ||||||||||
| Low Estimate | -0.40 | -0.37 | -0.49 | -0.40 | -0.20 | -0.20 | -0.25 | -0.21 | -0.24 | -0.25 | -0.09 | -0.09 | -0.46 | -0.40 | -0.09 | 0.17 | ||||||||||
| Consensus Estimate | -0.38 | -0.35 | -0.46 | -0.37 | -0.19 | -0.19 | -0.24 | -0.19 | -0.23 | -0.24 | -0.09 | -0.08 | -0.42 | -0.38 | -0.09 | 0.18 |
Pull Wall Street consensus for Actinium Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ATNM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ATNM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ATNM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();